Popular neuroscience loves nouns. Dopamine becomes motivation. Serotonin becomes happiness. Oxytocin becomes love. GABA becomes calm. The attraction is obvious: if a molecule has a psychological meaning, personality can be pictured as a mixing board with one labeled slider per trait.
The brain is less cooperative.
A neurotransmitter system is not a quantity poured into the brain. It is a distributed signaling architecture. To speak meaningfully about its “tone”, one has to include the entire stack through which signaling becomes function.
Begin before release. Precursors have to be available. Synthetic enzymes have to function. Transmitters must be packaged into vesicles. Neurons have characteristic firing patterns, including tonic background activity and phasic bursts. Release can vary by region and circumstance. Presynaptic autoreceptors regulate further release. After transmission, transporters clear molecules from the synapse, enzymes degrade them, and glial cells participate in uptake and recycling.
Then come receptors. A transmitter may act on several receptor families with different intracellular effects. Receptors can be presynaptic or postsynaptic, excitatory or inhibitory in functional consequence, densely expressed in one circuit and sparse in another. Their sensitivity changes with chronic stimulation. Receptors internalize, upregulate, downregulate, and interact with other signaling systems. The same systemic drug can therefore produce different effects across regions and across time.
Below the receptor lies another layer: second messengers, ion channels, gene transcription, plasticity, and the current state of the cell. Above the synapse lies the network: local excitation and inhibition, recurrent loops, long-range connectivity, oscillations, and the behavior of the entire circuit under changing inputs.
The effective psychological influence of a neurotransmitter is the result of all of this.
This is why two people can have similar measured concentrations and different functional states. One may have greater receptor density, another more efficient transport, another different autoreceptor feedback, another compensatory changes in a neighboring system. Conversely, two people with different molecular configurations may produce similar behavior because homeostasis has driven their networks toward comparable outputs.
The term tone should therefore be treated as a latent functional variable. It means something like the characteristic influence of a signaling system on a defined computation or circuit under specified conditions. It does not mean the total amount of a chemical in the body.
This distinction becomes particularly important when interpreting pharmacological evidence. Suppose a benzodiazepine reduces a person’s social anxiety and makes them more talkative. It would be tempting to conclude that GABA is the chemistry of sociability. That inference is wrong. The drug may have reduced threat signaling, weakened inhibitory control over behavior, impaired self-monitoring, produced mild euphoria, or changed several processes at once. The observed social behavior is the downstream result of a network perturbation.
The same caution applies to stimulants. Greater task initiation after amphetamine does not mean dopamine is a molecule of conscientiousness. Increased talkativeness does not mean dopamine is extraversion. The useful inference is narrower: dopaminergic perturbation changes computations involved in effort, salience, reinforcement, and action selection, and these computations contribute to behaviors that personality inventories summarize at a much higher level.
This full-stack view also explains time. Acute and chronic effects can point in different directions. A drug initially increases signaling; homeostatic responses then alter receptor sensitivity, release, transcription, or network balance. Tolerance develops. Withdrawal can temporarily produce a state opposite to the acute effect. Repeated exposure can sensitize some responses while tolerance develops to others. A personality pharmacology that ignores timescale would constantly mistake adaptation for contradiction.
The notion of functional tone has one obvious weakness: it risks becoming so inclusive that it explains everything after the fact. If every molecular and network process is folded into the word, what observation could falsify it?
The answer is operationalization. A latent variable becomes scientifically useful when it can be estimated from converging measures and used to predict outcomes that were not used to define it. A meaningful “reward-salience control” factor, for example, might combine behavioral tasks, imaging, pharmacological challenge responses, longitudinal motivation, and perhaps genetic or molecular measures. If the factor is stable enough, predicts relevant traits, and forecasts response to perturbation, it earns explanatory status. If it is merely a poetic name for a collection of inconsistent findings, it does not.
This points toward a change in vocabulary. Throughout the book, “high dopamine” or “low serotonin” should increasingly give way to more specific phrases: greater incentive salience, stronger punishment weighting, reduced inhibitory regulation, elevated tonic arousal, broader associative search, stronger social valuation, weaker model constraint. The transmitter systems remain important because they are among the mechanisms that control those operations. But the psychological language belongs one level higher.
There is another advantage to this approach. It makes room for interactions. Motivation does not depend on dopamine alone because effort is influenced by arousal, threat, fatigue, learning, expected reward, inhibitory control, and context. Social behavior does not depend on oxytocin alone because affiliation competes with threat, reward, learned attachment, status, and cultural norms. Cognitive flexibility does not belong to the endocannabinoid system alone because it emerges from the balance between associative generation and constraint across several networks.
Once “tone” is understood as a full-stack functional variable, personality pharmacology becomes less visually simple but more scientifically coherent. We are no longer looking for the molecule that is a trait. We are looking for the biological control architecture that makes some psychological policies easier for one person than another.
One more distinction completes the picture. Tone describes where a system usually sits. It says nothing about how far the system can move. Two people with the same resting dopaminergic tone may differ greatly in how much dopamine they can release when something important happens, or in how far their signalling can fall before it bottoms out. Call that second property the system’s potential range: the distance between what it does at rest and what it can be driven to do, upward and downward. It is built from the same stack as tone, from synthesis capacity and releasable stores to receptor reserve and the strength of homeostatic counter-regulation.
Potential range is not the same as how much a person’s state actually varies. Someone with a wide range may lead a quiet life that never tests it; someone with a narrow range may be pushed to its edges every week. And potential range is what gives drug effects their shape. A drug cannot push a system beyond its edges, so a person whose tone already sits near the ceiling has little room to go further up, and a stimulating drug may do little for them or tip them past the useful zone. Where a person sits within their own range may matter more than where they sit relative to other people.
The next step is to represent those differences without assuming that every relevant variable sits on a tidy bell curve. For that, the theory needs a multidimensional state space.